Partners in Cancer Research - www.ncri.org.uk - National Cancer Research Institute

UK CLINICAL RESEARCH NETWORK PORTFOLIO INCLUSION CRITERIA

When considering which funder to apply to, you may want to consider whether funding from that source will leave your study eligible for adoption of your study into the UK CRN Portfolio. The UK CRN Portfolio comprises the NIHR Clinical Research Network, the Scottish Clinical Research Portfolios, Northern Ireland Clinical Research Network and the NISCHR Clinical Research Infrastructure, each of which has specific eligibility criteria.

NIHR Clinical Research Network (England)

Please note that studies funded by the US NIH or European Framework Programmes only have medium priority regarding acceptance onto the NIHR CRN Portfolio. This means the studies will need formal consideration prior to acceptance, rather than being automatically eligible.

As of 1 June 2010 the NIHR Coordinated System for gaining NHS Permission (CSP) is the sole entry point for studies applying for inclusion on the NIHR Clinical Research Network (CRN) Portfolio. This is done via Integrated Research Application System (IRAS).

Eligibility for inclusion of studies in the NIHR CRN Portfolio

Details of studies automatically eligible for the NIHR CRN portfolio

Details of studies potentially eligible for the NIHR CRN portfolio

 

Devolved nations' research networks

Chief Scientist Office, Scotland’s list of funders eligible for the Scottish Clinical Research Portfolio

National Institute for Social Care and Health Research (Wales) portfolio adoption criteria

Northern Ireland Clinical Research Network criteria for portfolio inclusion